Blog
RSS FeedPosted by Michael Wonder on 20 Apr 2017
Full Federal Court confirms an application to list medicine on the PBS prior to patent expiry is a non-infringing act
19 April 2017 - Late last week, the Full Federal Court of Australia confirmed that the mere act of filing a ...
Posted by Michael Wonder on 20 Apr 2017
Propping up private health insurance is like putting lipstick on a pig
20 April 2017 - History is repeating itself. Medicare was created by the Whitlam government because of the abject failure ...
Posted by Michael Wonder on 19 Apr 2017
Private health insurance attacked for lack of value and transparency by experts
20 April 2017 - Consumers Health Forum publishes views of 20 experts in latest edition of Health Voices as part of ...
Posted by Michael Wonder on 11 Apr 2017
Federal budget 2017: budget razor gang to consider medicine scheme shake-up
11 April 2017 - The Turnbull government's budget razor gang is set to consider changes to the $10 billion Pharmaceutical Benefits ...
Posted by Michael Wonder on 07 Apr 2017
Drugs and manners of administration that meet the F2/multi-brand criteria (30 month clock for originator removal calculation) for the 2017 October Cycle
7 April 2017 - A list of drugs and manners of administration that meet the F2/multi-brand criteria (30 month clock for ...
Posted by Michael Wonder on 07 Apr 2017
Others to follow Enbrel biosimilar launch in Australia, Merck says
5 April 2017 - US pharma giant Merck has pledged to follow up the launch of a biosimilar etanercept in ...
Posted by Michael Wonder on 05 Apr 2017
Report on the collection of under co-payment data - 2015-16
5 April 2017 - The report on the collection of under co-payment data for 2015-16 is now available. ...
Posted by Michael Wonder on 04 Apr 2017
Brenzys lists on the Australian PBS and Pfizer denied discovery of documents to establish grounds for patent infringement
4 April 2017 - As of 1 April 2017, Samsung Bioepis' Brenzys, a biosimilar to Pfizer's Enbrel (etanercept), will join ...
Posted by Michael Wonder on 03 Apr 2017
Stan Zemanek’s widow Marcella calls for more funding into rare cancers
2 April 2017 - The widow of radio broadcaster Stan Zemanek has made an emotional plea to the federal government ...
Posted by Michael Wonder on 02 Apr 2017
Payers’ experiences with confidential pharmaceutical price discounts: a survey of public and statutory health systems in North America, Europe, and Australasia
1 April 2017 - Institutional payers for pharmaceuticals worldwide appear to be increasingly negotiating confidential discounts off of the official list ...
Posted by Michael Wonder on 01 Apr 2017
Schedule of Pharmaceutical Benefits - 1 April 2017
1 April 2017 - The 1 April 2017 issue of the Schedule of Pharmaceutical Benefits sees a number of new ...
Posted by Michael Wonder on 31 Mar 2017
Biosimilar awareness initiative - April 2017 update
1 April 2017 - The Initiative was announced in May 2015 as part of the Pharmaceutical Benefits Scheme Access and Sustainability ...
Posted by Michael Wonder on 30 Mar 2017
The hidden cost keeping your health insurance premiums high
30 March 2017 - Private health insurance costs for everyone could drop dramatically if the Federal Government tackled murky practices relating ...
Posted by Michael Wonder on 29 Mar 2017
$30m damages for infringement of Bayer’s Australian Yasmin patent - a “small” jurisdiction with big benefits
29 March 2017 - In a recent landmark Australian Federal Court decision, Bayer v Generic Health FCA 250, Bayer was awarded ...
Posted by Michael Wonder on 29 Mar 2017
National Health Amendment (Pharmaceutical Benefits) Act 2017
29 March 2017 - The National Health Amendment (Pharmaceutical Benefits) Bill 2016 was passed in the House of Representatives on ...